SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

BLAU3 (BLAU3) News

Follow BLAU3 (BLAU3) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol BLAU3 Asset market Sector Markets 90 days 1 Updated Sep 08, 2026, 10:05 PM UTC Open live news feed
L Blau Farmacêutica: Growth driven by biosimilars, mAbs, and operational efficiency boosts margins and global reach Structural growth is fueled by patent expirations, biosimilars, and an aging population, while leadership in complex hospital drugs and a robust mAb pipeline drive expansion. Operational improvements, disciplined investm EQUITY | Sep 08, 2026, 10:05 PM UTC